In summary, we expand the clinical and mutational spectrum of FBXO11-associated NDD and provide evidence that while some clinical variability may be influenced by mutation type and location, most missense variants and LGD variants are likely to function through a shared pathomechanism of loss-of function and haploinsufficiency. The gene discussed is FBXO11; the disease is Neurodevelopmental delay.